Frontlight ResearchEarly access
Peripheral artery disease trials in Ecuador
1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Quito
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01